| MEGX | monoethylglycinexylidide |
|---|
| monoethylglycinexylidide |
the principal active metabolite of lidocaine, produced in the liver; measurement of the conversion of lidocaine to MEGX is used to assess hepatic function.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|---|
| monoethylglycinexylidide t. |
(for liver function): MEGX test; the plasma concentration of monoethylglycinexylidide (MEGX) is measured 15 or 30 minutes after the intravenous injection of lidocaine; MEGX levels are reduced in impaired liver function.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|